Cosopt sine Augndropar, lausn 20 mg/ml+5 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

cosopt sine augndropar, lausn 20 mg/ml+5 mg/ml

santen oy* - dorzolamidum hýdróklóríð; timololum maleat - augndropar, lausn - 20 mg/ml+5 mg/ml

Daren Tafla 5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

daren tafla 5 mg

teva b.v.* - enalapril maleate - tafla - 5 mg

Timosan Depot í stakskammtaíláti Augnhlaup í stakskammtaíláti 1 mg/g Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

timosan depot í stakskammtaíláti augnhlaup í stakskammtaíláti 1 mg/g

santen oy* - timololum maleat - augnhlaup í stakskammtaíláti - 1 mg/g

Dorzolamide/Timolol Alvogen Augndropar, lausn 20mg/ml+5 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

dorzolamide/timolol alvogen augndropar, lausn 20mg/ml+5 mg/ml

alvogen ehf. - dorzolamidum hýdróklóríð; timololum maleat - augndropar, lausn - 20mg/ml+5 mg/ml

Fotil Forte Augndropar, lausn í stakskammtaíláti 5 mg + 40 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

fotil forte augndropar, lausn í stakskammtaíláti 5 mg + 40 mg/ml

santen oy* - pilocarpini chloridum nfn; timololum maleat - augndropar, lausn í stakskammtaíláti - 5 mg + 40 mg/ml

Xalcom Augndropar, lausn Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

xalcom augndropar, lausn

upjohn eesv - latanoprostum inn; timololum maleat - augndropar, lausn

Methergin Stungulyf, lausn 0,2 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

methergin stungulyf, lausn 0,2 mg/ml

essential pharma limited - methylergometrinum maleat - stungulyf, lausn - 0,2 mg/ml

Travoprost/Timolol Medical Valley Augndropar, lausn 40 míkróg/ml + 5 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

travoprost/timolol medical valley augndropar, lausn 40 míkróg/ml + 5 mg/ml

medical valley invest ab - travoprostinum inn; timololum maleat - augndropar, lausn - 40 míkróg/ml + 5 mg/ml

Emtricitabine/Tenofovir disoproxil Mylan Evrópusambandið - íslenska - EMA (European Medicines Agency)

emtricitabine/tenofovir disoproxil mylan

mylan pharmaceuticals limited - meðferð með eviplera nýrnastarfsemi disoproxil maleat - hiv sýkingar - veirueyðandi lyf til almennrar notkunar - treatment of hiv-1 infection:emtricitabine/tenofovir disoproxil mylan is indicated in antiretroviral combination therapy for the treatment of hiv-1 infected adults (see section 5. emtricitabine/tenofovir disoproxil mylan is also indicated for the treatment of hiv-1 infected adolescents, with nrti resistance or toxicities precluding the use of first line agents, (see sections 4. 2, 4. 4 og 5. pre-exposure prophylaxis (prep):emtricitabine/tenofovir disoproxil mylan is indicated in combination with safer sex practices for pre-exposure prophylaxis to reduce the risk of sexually acquired hiv-1 infection in adults and adolescents at high risk (see sections 4. 2, 4. 4 og 5.

Doptelet Evrópusambandið - íslenska - EMA (European Medicines Agency)

doptelet

swedish orphan biovitrum ab (publ) - avatrombopag maleate - blóðflagnafæð - antihemorrhagics - doptelet er ætlað fyrir meðferð alvarlega blóðflagnafæð í fullorðinn sjúklinga með langvarandi lifrarsjúkdóm sem eru áætlað er að gangast undir innrásar aðferð. doptelet is indicated for the treatment of primary chronic immune thrombocytopenia (itp) in adult patients who are refractory to other treatments (e. barkstera, immúnóglóbúlín).